Paclitaxel nanocrystals for overcoming multidrug resistance in cancer
about
Prodrug Strategies for PaclitaxelInjected nanocrystals for targeted drug deliveryEnabling anticancer therapeutics by nanoparticle carriers: the delivery of PaclitaxelIn Vivo Biodistribution and Anti-Tumor Efficacy Evaluation of Doxorubicin and Paclitaxel-Loaded Pluronic Micelles Decorated with c(RGDyK) PeptideCarboxymethylcellulose-based and docetaxel-loaded nanoparticles circumvent P-glycoprotein-mediated multidrug resistance.Vitamin E transporters in cancer therapy.Shape-controlled paclitaxel nanoparticles with multiple morphologies: rod-shaped, worm-like, spherical, and fingerprint-like.Elucidating the in vivo fate of nanocrystals using a physiologically based pharmacokinetic model: a case study with the anticancer agent SNX-2112.Poloxamer 407/TPGS mixed micelles for delivery of gambogic acid to breast and multidrug-resistant cancer.Optimized zein nanospheres for improved oral bioavailability of atorvastatinBiodegradable mixed MPEG-SS-2SA/TPGS micelles for triggered intracellular release of paclitaxel and reversing multidrug resistance.Beyond the imaging: limitations of cellular uptake study in the evaluation of nanoparticles.Polymeric drugs: Advances in the development of pharmacologically active polymers.Architectural layer-by-layer assembly of drug nanocapsules with PEGylated polyelectrolytes.PEG-derivatized embelin as a nanomicellar carrier for delivery of paclitaxel to breast and prostate cancersKey structure of brij for overcoming multidrug resistance in cancerVitamin E reverses multidrug resistance in vitro and in vivo.Paclitaxel Nano-Delivery Systems: A Comprehensive Review.Recent trends in cancer drug resistance reversal strategies using nanoparticles.Nanocrystals for the parenteral delivery of poorly water-soluble drugsPolymeric micelles: nanocarriers for cancer-targeted drug deliveryDeveloping nanocrystals for cancer treatment.TPGS/Phospholipids Mixed Micelles for Delivery of Icariside II to Multidrug-Resistant Breast Cancer.Design and evaluation of injectable niclosamide nanocrystals prepared by wet media milling technique.Bypassing multidrug resistance in cancer cells with biodegradable polymer capsules.Study on orally delivered paclitaxel nanocrystals: modification, characterization and activity in the gastrointestinal tract.Drug nanocrystals for cancer therapy.Enhancing Docetaxel Delivery to Multidrug-Resistant Cancer Cells with Albumin-Coated Nanocrystals.Recent developments in d-α-tocopheryl polyethylene glycol-succinate-based nanomedicine for cancer therapy.Evaluation of the antitumor effects of vitamin K2 (menaquinone-7) nanoemulsions modified with sialic acid-cholesterol conjugate.Soluplus/TPGS mixed micelles for dioscin delivery in cancer therapy.Preparation and in-vitro/in-vivo characterization of trans-resveratrol nanocrystals for oral administration.Celecoxib nanosuspension: single-step fabrication using a modified nanoprecipitation method and in vivo evaluationNanocrystals of Poorly Soluble Drugs: Drug Bioavailability and Physicochemical Stability
P2860
Q26745997-DD6FDF74-E147-4FD3-88E6-8AFA2674A63AQ26752396-2EC12BFB-F0A5-411F-9897-89B3D4D85C01Q26999288-925AD91D-6C7F-4F30-BC76-6580AC379AEFQ28550452-C766F504-27D5-4971-BFCB-E5601558FD8BQ34005719-41BA02E5-FEB9-45E9-A18F-7081154E331BQ34451618-9E1DFA24-0981-4F4D-998D-488B2C71D21BQ35100764-60C3186D-D348-455F-A512-167AE8F1E409Q35284235-940E3D62-9A75-4686-A015-A8CB42CD6709Q35771377-5BDA3040-734D-4E60-A10C-37401D992BBCQ35780982-FC5CD4E8-919E-4558-B461-BB57B89DC711Q36175486-4D7CD4EA-1334-4817-9E31-611775979DB8Q36247616-AE73DFC4-8143-4E16-AC98-715A5A0FC163Q36307604-E8341C74-9774-4EB0-BC59-C7820401EE3CQ36375582-739BCEED-9833-49D6-899C-D48350E22B96Q36485032-28D5704C-90A4-4B5E-892B-BBCE86E008A2Q36615913-CA73B659-1EA5-4E84-8102-A91D6B3EC601Q36936239-F9EC9AC8-65A8-4739-9CB4-896BE1AB5682Q37250009-2D7B741A-E172-4712-94FA-C7D92DD9B20DQ37984588-1C997076-96F0-4E50-B2DF-404EB34E090DQ38104343-2923D1D0-7913-4608-A73A-098B079E633AQ38202058-4CAB78D7-76A9-425E-BEF1-FBBECC38B933Q38570503-B8DD8A68-75C1-447A-8C78-C44E123AAA0FQ38842165-4299F826-CE6C-4A4A-BC5D-20D376D042F0Q38958062-71CC8F64-DC90-4165-A8B8-A51C142EE8D8Q39639787-BB8B0C2D-863F-4FEB-BC3E-FC202D309A14Q47117242-9F616652-63E4-4D52-A391-37C2D830C874Q47433211-3D19CF4C-B00F-4FE9-A4FB-B618672186B7Q47712879-A3804D73-6B8D-4D2A-B556-68EBA0D103C0Q47814018-1829FEC9-7FA0-4272-B3E2-EC1787C627BEQ47910995-20C92131-99C1-4DE0-B859-1BFD6F9FCFADQ50795845-CA876B1A-4B74-433C-8D1B-E694A8BDA747Q52790753-1D9D1D2E-635D-4EAD-AD39-DE3DEE7F7D6EQ58624617-EC2B7383-79B8-4B27-A5B8-069919609CC0Q58726467-758D93FA-BC55-468E-ACD0-492C7D06A691
P2860
Paclitaxel nanocrystals for overcoming multidrug resistance in cancer
description
2010 nî lūn-bûn
@nan
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
2010年论文
@zh
2010年论文
@zh-cn
name
Paclitaxel nanocrystals for overcoming multidrug resistance in cancer
@ast
Paclitaxel nanocrystals for overcoming multidrug resistance in cancer
@en
type
label
Paclitaxel nanocrystals for overcoming multidrug resistance in cancer
@ast
Paclitaxel nanocrystals for overcoming multidrug resistance in cancer
@en
prefLabel
Paclitaxel nanocrystals for overcoming multidrug resistance in cancer
@ast
Paclitaxel nanocrystals for overcoming multidrug resistance in cancer
@en
P2093
P2860
P356
P1476
Paclitaxel nanocrystals for overcoming multidrug resistance in cancer
@en
P2093
P2860
P304
P356
10.1021/MP100012S
P407
P577
2010-06-01T00:00:00Z